Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On August 18, 2025, Lixte Biotechnology Holdings, Inc. (the “Company”) issued a news release to provide an update with respect to recent corporate
Financial Statements and Exhibits. (d) Exhibits The Company is filing as part of this Current Report on Form 8-K the exhibits listed on the accompanying Index t